Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOOCOST: Patient Blood Management in Cardiac Surgery
NCT04141631Completed
- Sponsor
- CHU Montpellier
- Start
- Jan 2020
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of erythropoietin and ferric carboxymaltose in anemia (2 arms), sponsored by CHU Montpellier. Primary endpoint: Transfusion incidence at hospital discharge. Started Jan 2020; status: completed.
02
Drugs
erythropoietinferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04141631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141631.